Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. on February 5, 2019. The report details a material definitive agreement entered into on the same date regarding the amendment of existing warrant agreements. The filing does not provide a specific reporting period for financial results as it is a current report of a specific corporate event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a warrant amendment.
Material Changes
The primary material change involves the amendment of two-year warrants issued in January and February 2015. Key changes include:
- Expiration Extension: The expiration dates for the warrants were extended by two additional years.
- Exercise Price Adjustment: The exercise price for warrants to purchase 266,667 shares (originally $3.00 per share) was increased to $3.35 per share.
- Unchanged Terms: The exercise price for warrants to purchase 420,000 shares at $6.00 per share remained unchanged.
The specific new expiration dates are:
- January 29, 2021: 266,667 shares at $3.35 and 266,667 shares at $6.00.
- February 10, 2021: 140,000 shares at $6.00.
- February 23, 2021: 13,333 shares at $6.00.
Guidance, Outlook, and Risks
The filing does not contain management guidance, outlook, or general risk factors. The amendment was executed with affiliates of the Company, specifically:
- A subsidiary of IDT Corporation (a greater than five percent stockholder).
- Entities controlled by Mr. Paul Packer (a greater than five percent stockholder).
Investor Verification Checklist
- Verify the total number of shares subject to the amended warrants (686,667 total).
- Confirm the new exercise prices ($3.35 and $6.00) and their respective share counts.
- Review the specific expiration dates for each tranche of warrants (ranging from January to February 2021).
- Identify the specific affiliates involved in the amendment to assess potential related-party transaction implications.